AKT1 and breast carcinoma: In addition, iturin A re-sensitized the docetaxel resistant MDA-MB-231 and MDA-MB-468 breast cancer cells by reducing phosphorylated-Akt expression levels, which led to the inactivation of the Akt pathway [65].